✦ LIBER ✦

Infections after auxiliary partial liver transplantation. Experiences in the first ten patients

✍ Scribed by J. H. van Zeijl; J. F. Sluiters; M. F. Michel; H. J. Metselaar; P. J. A. Willemse; S. W. Schalm; H. A. Bruining; O. T. Terpstra; A. C. M. Kroes

Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 1023 KB
Volume: 18
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01642102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isoniazid-related fulminant hepatic fail

✍ Umberto Cillo; Marco Bassanello; Alessandro Vitale; Lorenzo D’Antiga; Giacomo Za 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 270 KB

Pattern of bacterial and fungal infectio

Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: An 11-year single-center experience

✍ Hanaa Nafady-Hego; Hamed Elgendy; Walid El Moghazy; Kazuhiko Fukuda; Shinji Uemo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

Infection after pediatric living donor liver transplantation (LDLT) is a major cause of morbidity and mortality. Here, we sought to determine the incidence, timing, location, and risk factors for bacterial and fungal infections. We retrospectively investigated infection for 3 postoperative months in

Retrospective review of the incidence of

Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

✍ Ashley N. Bedel; Trina S. Hemmelgarn; Rohit Kohli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

Cytomegalovirus (CMV) is the most common viral infection after solid organ transplantation (SOT). Safe and effective prophylactic regimens that decrease its incidence after SOT are essential for long-term graft survival. Although valganciclovir is not Food and Drug Administration-approved for CMV pr